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A B S T R AC T
Submaximal step tests are often used for estimation of maximum oxygen consumption (VO2max) in 
humans. The validity of the Actiheart step test for VO2max estimation was not fully studied yet. There-
fore, purpose of the study was to estimate VO2max using the Actiheart step test and to compare the 
data with measured VO2max in endurance trained athletes (ATH) and healthy non-athletes (CON).
68 ATH (54% men, 28.0±5.4 yrs, 20.9±1.7 kg∙m-2) and 63 CON (46% men, 27.6±5.1 yrs, 22.1±1.7 kg∙m-2) 
performed the Actiheart step test and a spiroergometry for assessment of VO2max. In addition, rest-
ing metabolic rate (RMR; indirect calorimetry), maximum heart rate (HRmax; heart rate monitoring 
system during spiroergometry), and sleeping heart rate (SHR; Actiheart 6-day long term measure-
ment) were determined. Validity of two different Actiheart software entry modes was assessed: (1) 
AHraw (estimated RMR [Schofield] and HRmax [Tanaka], SHR = 70 bpm) and (2) AHcomplete (mea-
sured RMR, HRmax, and SHR). Validity was investigated using linear regression (R2 and standard error 
of the estimate (SEE)) and repeated-measures ANOVA with a Bonferroni post-hoc correction. The 
level of significance was set to α=0.05.
VO2max estimated by AHraw was significant related to measured VO2max in women CON (R
2=0.22; 
p<0.05), whereas when VO2max was estimated by AHcomplete the relation was significant in women 
ATH and CON, and in men CON (R2=0.17-0.24; p<0.05). AHraw significantly underestimated VO2max 
in the total sample by 8% (51.4±10.2 vs. 55.9±7.6 ml∙kg-1∙min-1; p<0.0001), whereas no significant 
difference between AHcomplete and the criterion method was found (57.0±11.1 vs. 55.9±7.6 ml∙ 
kg-1∙min-1; p=0.26). 
The Actiheart step test is an acceptable tool for the estimation of VO2max if an error within 8% can be 
tolerated. However, accuracy of the VO2max prediction is much improved when entering measured 
variables, such as RMR, SHR, and HRmax, into the software.  
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Introduction
Maximum oxygen consumption (VO2max), a key indicator of 
cardiorespiratory fitness, is used in both athletic and health 
settings, as a determinant of physical performance (Bassett 
& Howley, 2000) or as a predictor of health risk and longevity 
(Kodama et al., 2009). VO2max-testing is usually performed on a 
treadmill or a cycle ergometer while oxygen uptake and expired 
carbon-dioxide are measured with a respiratory gas analyzer. 
The workload is progressively increased until the participant 
reaches volitional exhaustion (after a minimum of 5 min (tread-
mill) or 7 min (cycle), up to 26 min (Midgley, Bentley, Luttikholt, 
McNaughton, & Millet, 2008)). However, maximum exercise tests 
are time consuming, expensive and depend on physiological 
expertise (Björkman, Ekblom-Bak, Ekblom, & Ekblom, 2016). In 
addition, some individuals from the general population cannot 
achieve the maximal effort required for the determination of 
VO2max. Furthermore, there are contraindications for maximum 
exercise tests (American Thoracic Society & American College 
of Chest Physicians, 2003). These contraindications include un-
controlled asthma, syncope, acute myocardial infarction, and 
respiratory failure. Therefore, several indirect methods to esti-
mate VO2max have been developed, where VO2max is predicted 
from submaximal exercise results. Most of these tests use the 
linear relationship between heart rate (HR) and oxygen uptake 
(VO2). The VO2max is then predicted by extrapolation of the sub-
maximal values to an estimated maximum heart rate (HRmax). 
Submaximal tests thus allow evaluation of cardiorespiratory 
fitness in a population, in which the direct determination of 
VO2max is not possible (Björkman et al., 2016).
The Actiheart is a lightweight (10 g), waterproof combined 
HR and movement sensor (accelerometer) designed to non-
invasively assess daily physical activity levels (Cambridge 
Neurotechnology Ltd., Papworth, UK). The Actiheart was shown 
to give accurate estimations of activity energy expenditure 
against indirect calorimetry during a wide range of activities 
in men and women in both laboratory (Thompson, Batterham, 
Bock, Robson, & Stokes, 2006) and field (Crouter, Churilla, & 
Bassett, 2008) settings. A good level of agreement between 
Actiheart and doubly labelled water measured daily total en-
ergy expenditure was found in adult men and women (Brage 
et al., 2015), in children and adolescents (Butte et al., 2010), and 
in lean and overweight men of various fitness levels (Villars et 
al., 2012). The Actiheart needs to be individually calibrated for 
each person with a standard step test, a built-in function of the 
Actiheart software. During stepping, the relationships between 
actimetry and HR vs. work rate are assessed. The step test also 
yields estimated VO2max values, obtained by extrapolating the 
HR vs. work rate regression line to the estimated or measured 
HRmax for the individual. No studies assessed the validity of 
the VO2max estimation using the Actiheart step test. The pur-
pose of the study was to estimate VO2max using the Actiheart 
step test in AHraw and AHcomplete modes (see “Methods”) 
and to compare the results with measured VO2max over a 
range of aerobic capacities. The results were expected to fill a 
gap in the knowledge regarding the practical use and precision 
of the Actiheart modes for estimating VO2max in comparison 
to the VO2max ergometer measurements for athletic and non-
athletic populations.
Methods
Participants
We recruited by advertisement 68 competitive endurance ath-
letes (ATH; 31 women, 37 men; regular endurance training vol-
ume ≥ 300 min ∙ wk-1 and participation in competitions) and 63 
healthy, non-endurance-trained nonsmoking controls (CON; 
34 women, 29 men; max. 150 min ∙ wk-1 moderate endurance 
training). Most but not all participants were workers, students 
or athletes located on the campus of the Swiss Federal Institute 
of Sports Magglingen. All participants had to be weight-stable 
(< 2 kg of weight difference in the last 3 months) with a Body 
Mass Index (BMI) between 18.5 and 25 kg ∙ m-2, and aged be-
tween 18 and 40 years. Participants were excluded if they were 
smoking, pregnant, lactating, dieting, suffering from metabolic 
disease and/or eating disorders, or taking medication (apart 
from contraceptives). Athletes were excluded from the study 
if they had changed their training habits within the last four 
weeks before the experiments (e.g., due to injury or disease). 
All experimental procedures were approved by the Regional 
Ethics Committee in Berne, Switzerland (KEK-number 090/15), 
and the study was carried out according to the recommenda-
tions of the Helsinki Declaration. Written informed consent of 
the participants was obtained before any testing.
Study design
The participants were recruited by advertisement. They came 
to the testing center on two separate testing days, having re-
frained from strenuous physical activity ≥ 24 h. After provid-
ing written informed consent, on the first day the participants 
completed, in a fasted state (≥ 12 h absence of any food or fluid 
intake, ≥ 36 h absence of alcohol or caffeine intake) measure-
ments in the following order: 1) anthropometry and body com-
position; 2) resting metabolic rate (RMR); and 3) a step test using 
the in-built function of the Actiheart. One week after the first 
measurement day, the participants did an incremental exercise 
test (VO2max) in a non-fasted state. In the days between the 
two testing days the participants wore an Actiheart for at least 
7 days. All tests were carried out in Magglingen (Switzerland) at 
an altitude of 950 m. 
Estimation of VO2max with the Actiheart
The Actiheart was clipped onto two standard ECG electrodes 
(3MTM Red DotTM Electrode 2560; 3M Health Care, St. Paul, USA) 
on the chest of the participant according to manufacturer’s in-
structions and worn day and night (Brage et al., 2006). The de-
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vice was individually calibrated for each participant using the 
standard step test, a built-in function of the Actiheart software 
version 4.0.92 (Cambridge Neurotechnology Ltd., Papworth, 
UK). In short, the participants stepped up and down a 195 mm 
high step for eight minutes while stepping rate was ramped 
linearly from 15 step cycles ∙ min-1 (one step cycle is “up, up, 
down, down”) to 33 step cycles ∙ min-1 at the end (rate of change 
2.5 body lifts ∙ min-1). Participants were advised to stop the test 
if they felt uncomfortable. After the end of the test, participants 
were requested to stand still for two minutes with the Actiheart 
still fitted while not speaking during which recovery HR was as-
sessed. The mechanical power of the step test (mass-specific lift 
work rate) was calculated as 9.81 m ∙ s-2 x step height (m) x lift 
frequency (number of body weight lifts ∙ min-1) and expressed 
in J ∙ kg-1 ∙ min-1. The Actiheart software uses linear regression to 
model the relationship between work rate and HR during step-
ping. To estimate the VO2max, the regression line was extrap-
olated to the estimated HRmax for each participant. The pre-
dicted VO2max in L ∙ kg
-1 ∙ min-1 was then calculated as a maxi-
mum mechanical power in J ∙ kg-1 ∙ min-1 divided by a factor of 
20.2 (assuming an invariant net efficiency of 20%). The HRmax 
was defined in two ways: (1) estimated by use of the Tanaka 
equation (Tanaka, Monahan, & Seals, 2001); and (2) measured 
during a maximum exercise test (see section “Measurement of 
VO2max”). 
Total energy expenditure (TEE) and activity energy expenditure 
were estimated by analyzing 6 full-day (24 h) recordings of HR 
and body movement with a 15-second averaging epoch set-
ting. During the recording period participants were requested 
to continue their habitual life routine and physical activities. 
Sleeping heart rate (SHR) was measured as a mean of the 120 
lowest HR recordings during 24 h, the SHR for a full six-day pe-
riod was determined as the mean value of the six SHR record-
ings. TEE was calculated as sum of RMR (measured by indirect 
calorimetry, see section “Resting metabolic rate”), activity ener-
gy expenditure, and diet-induced thermogenesis (estimated as 
10% of TEE (Manore & Thompson, 2010)). Physical activity level 
(PAL) was calculated as TEE/RMR.
For the validity testing, two inbuilt scenarios of the Actiheart 
step test were looked at: (1) “AHraw”. In this mode SHR is set to 
70 bpm, RMR is estimated by the Schofield equation (Schofield, 
1985), and HRmax is estimated by use of the Tanaka formula 
(Tanaka et al., 2001); and (2) “AHcomplete”. In this mode SHR, 
measured during the long-term recordings of the Actiheart, 
RMR, measured using indirect calorimetry, and HRmax, mea-
sured during a maximum exercise test, are manually entered 
into the Actiheart software.
Measurement of VO2max
Before exercise testing each participant filled out the German 
(Marti, Villiger, Hintermann, & Lerch, 1998) or French (Société 
canadienne de physiologie de l’exercice, 2002) version of the 
Physical Activity Readiness Questionnaire (PAR-Q). Only if all 
items were answered with “no”, participants were allowed to 
start the exercise testing. The test was performed on a tread-
mill (women: model mercury; men: model venus, h/p/Cosmos 
Sports & Medical GmbH, Traunstein, Germany). Treadmill in-
clines were set at 4° throughout the test. After a 5-min warm-
up jog, non-athletic participants begun running at 7 km ∙ h-1, 
whereas participants from the athlete group started at 9 km ∙ 
h-1. The speed was increased by 1 km ∙ h-1 every minute for the 
first 3 minutes of the test and thereafter by 0.5 km ∙ h-1 every 
30 s until exhaustion (Steiner & Wehrlin, 2011). Gas exchange 
was measured breath-by-breath with an open-circuit system 
(Quark CPET; COSMED Srl, Rome, Italy), which was calibrated 
before each test according to manufacturer’s instructions. 
VO2 data was processed using 10-second time averages. 
VO2max was determined as the highest 30-second VO2 aver-
age for the test (Robergs, Dwyer, & Astorino, 2010). Heart rate 
was continuously registered with a wireless HR monitoring 
system (model SZ990; COSMED Srl, Rome, Italy). If the primary 
criteria of a plateau in oxygen uptake (defined as an increase of 
VO2 < 2.1 mL ∙ kg
-1 ∙ min-1) was not reached by the participant 
(n = 4), then the secondary criteria of a RQ value ≥ 1.10, and a 
HR close (± 10 bpm) to the age-predicted HRmax (Tanaka et al., 
2001) were used to determine whether the participant reached 
maximal effort and thus VO2max. VO2max-tests were carried 
out at a mean room temperature of 21.8 ± 1.0°C, a humidity 
of 39.8 ± 10.1%, and an air pressure of 914 ± 7 hpa. In general, 
a temperature range of 20 to 22°C in a cool, dry environment 
(< 50% humidity) is considered comfortable for exercise testing 
(Myers et al., 2009).
Anthropometric data and body composition
Body weight was measured to the nearest 0.1 kg on a calibrat-
ed beam scale (Seca 877, Seca, Hamburg, Germany) and body 
height was measured to the nearest 0.5 cm with a height rod 
(Seca 213, Seca, Hamburg, Germany), with the participants in 
light clothing and without shoes. 
Body composition was assessed using Lunar iDXA (GE 
Healthcare, Madison, WI, USA). Calibration of the iDXA was 
performed and checked on a daily basis before testing using a 
calibration phantom. Participants voided their bladder before 
the scan. The participants were in underwear and all metal ar-
tefacts were removed. During measurement, participants were 
in supine position on the scanning table with their ankles and 
legs fixed using supports. Arms were positioned to the side 
with the palms flat on the table. Participants were requested 
to stay still during the measurement. Whole body scans were 
performed according to the manufacturer’s instructions, and 
adipose tissue mass, lean tissue mass, and bone mineral con-
tent were derived (enCore software v. 11.10; GE Healthcare, 
Madison, WI, USA). Total body composition estimates with the 
Lunar iDXA have been reported to be excellent in other studies 
(Carver, Christou, & Andersen, 2013; Hind, Oldroyd, & Truscott, 
2011).
CISS 4 (2019) March 2019 I Article 003 I 4
J. Heydenreich, Y. Schutz, B. Kayser & K. Melzer Actiheart step test validity
2017). The R2 and standard error of the estimate (SEE) were 
calculated by linear regression, where measured VO2max was 
entered as dependent variable and estimated VO2max as inde-
pendent variable. Levels of agreement between Actiheart and 
measured values were further expressed as mean difference 
with Limits of Agreement (mean difference ± 1.96 SD) (Bland 
& Altman, 1999).
Results
Participants
Data of in total 50 women (24 ATH and 26 CON) and 41 men (22 
ATH and 19 CON) with valid Actiheart, VO2max, and RMR mea-
surements were included into the analysis. The Table 1 presents 
the anthropometric data, body composition, RMR and VO2max 
of the participants. The VO2max ranged from 39.1 – 65.4 ml ∙ 
kg-1 ∙ min-1 in women and 42.8 – 78.4 ml ∙ kg-1 ∙ min-1 in men. 
Validity of the Actiheart step test for estimation of VO2max
The Pearson’s correlation analyses revealed moderately cor-
related data of AHraw and the criterion method only in wom-
en CON (r = 0.46, p < 0.05), whereas the correlation between 
AHcomplete and measured VO2max was significant in women 
ATH, women CON, and men CON (r = 0.41 – 0.49, all p < 0.05; 
Table 2), and r was interpreted as moderate association. The 
MAE, MAPE, and SEE for all groups are presented in Table 2. 
In women and men ATH the AHraw significantly underesti-
mated VO2max (p < 0.05), whereas in the CON groups no sig-
nificant differences between estimated and measured VO2max 
were found. For AHcomplete, VO2max was significantly un-
derestimated in women ATH (p = 0.03), and overestimated in 
men CON (p = 0.03), whereas no significant differences were 
obtained in women CON and men ATH. When looking at the 
total sample, significant differences between AHraw and the 
measured VO2max (51.4 ± 10.2 vs. 55.9 ± 7.6 ml ∙ kg
-1 ∙ min-1; 
p < 0.0001) were observed, whereas the difference between 
AHcomplete and VO2max was non-significant (57.0 ± 11.1 vs. 
55.9 ± 7.6 ml ∙ kg-1 ∙ min-1; p = 0.26). The range of the MAPE across 
all groups was 11.4 – 17.7% and 10.8 – 14.7% for AHraw and 
AHcomplete, respectively (Table 2). The absolute difference be-
tween measured and estimated VO2max by use of AHraw was 
smaller than 5 ml ∙ kg-1 ∙ min-1 in 29% (n = 7), 54% (n = 14), 27% 
(n = 6), and 58% (n = 11) in women ATH, women CON, men ATH, 
and men CON, respectively. When VO2max was estimated by 
AHcomplete, the absolute difference between measured and 
estimated VO2max was smaller than 5 ml ∙ kg
-1 ∙ min-1 in 42% (n = 
10), 39% (n = 10), 50% (n = 11), and 37% (n = 7) of women ATH, 
women CON, men ATH, and men CON, respectively. 
The results of the linear regression analyses are presented in 
Table 3. In women CON a statistically significant relationship 
between VO2max estimated by AHraw and the measured val-
Resting metabolic rate
RMR was assessed by indirect calorimetry using a venti-
lated hood system (Quark CPET; COSMED Srl, Rome, Italy). 
Calibrations of the gas analyzer and flowmeter were carried 
out before each test according to manufacturer’s instruc-
tions. After acclimatization and relaxing for 30 min on a bed, 
a ventilated hood was placed over the participant’s head and 
measurements were started. VO2 and carbon dioxide produc-
tion (VCO2) were measured for 30 min at 10-second intervals 
with participants remaining motionless in supine position in a 
thermoneutral environment (20 - 25 °C (Compher, Frankenfield, 
Keim, Roth-Yousey, & Evidence Analysis Working Group, 2006)). 
The first 5 min were eliminated as acclimatization artifact. From 
the remaining 25 min an interval of 5 consecutive minutes with 
a < 10% coefficient of variation of VO2 and VCO2 was consid-
ered as steady state. VO2 and VCO2 were then used to calculate 
RMR using the abbreviated Weir equation (Weir, 1949). Since 
respiratory quotient (RQ, defined as the ratio of VCO2 and VO2) 
measures at rest < 0.70 and > 1.00 suggest protocol violations 
or inaccurate gas measurement (Compher et al., 2006), par-
ticipants with RQ-values outside of the plausible range should 
be excluded from data analysis (n = 1). The obtained RQ for all 
measurements was 0.76 ± 0.04 and the mean coefficients of 
variation of VO2 and VCO2 were 3.8 ± 1.5% and 5.0 ± 1.9%. RMR 
measurements took place at a mean temperature of 21.9 ± 
1.2°C, 40.0 ± 10.2% humidity, and an air pressure of 914 ± 7 hpa.
Statistics
Statistical analyses were performed using the statistical soft-
ware SPSS version 24 for MS-Windows (IBM Corp., Chicago, 
IL, USA). Mean values and standard deviations (SD) were 
calculated and data was checked for normality using the 
Shapiro-Wilk-test. All parameters were normal distributed 
with the exception of age, body fat (%), fat-free mass (kg), RMR 
(kcal ∙ d-1), VO2max (L ∙ min
-1), recovery HR, and PAL. Group differ-
ences were tested by independent t-tests and Mann-Whitney-
U-tests (α = 0.05). The validity of the Actiheart step test was 
first investigated using Pearson’s Product moment correlation 
analysis. The correlation coefficients (r) were classified accord-
ing to Cohen (Cohen, 1988). An r between 0.10-0.29 was con-
sidered a small, between 0.30-0.49 a moderate and between 
0.50-1.0 a strong association. The data were further analyzed 
using a repeated-measures ANOVA with a Bonferroni post-hoc 
correction to compare measured VO2max, estimated VO2max 
by AHraw, and estimated VO2max by AHcomplete. In addition, 
the mean absolute error (MAE) and the mean absolute per-
centage error (MAPE) of AHraw and AHcomplete compared to 
the criterion measure were computed. Since no standardized 
threshold exists for high or low MAPE, we considered a MAPE 
≥ 10% as an indicator of inaccuracy as suggested by other au-
thors (Boudreaux et al., 2018; Lee, Kim, & Welk, 2014; Nelson, 
Kaminsky, Dickin, & Montoye, 2016; Roos, Taube, Beeler, & Wyss, 
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Table 1: Participant characteristics of the men and women athletes (ATH) and controls (CON).
Legend: Results are expressed as mean ± standard deviation. a significantly different from CON of the same sex (p < 0.05), 
b significantly different from CON of the same sex (p < 0.01), c significantly different from CON of the same sex (p < 0.0001)
Women Men
ATH (n = 24) CON (n = 26) ATH (n = 22) CON (n = 19)
Age (years) 30.0 ± 5.5 27.4 ± 4.9 25.8 ± 4.4 27.1 ± 5.4
Body mass (kg) 57.0 ± 5.9 a 61.6 ± 6.6 69.9 ± 6.8 72.4 ± 7.3
Height (cm) 168 ± 5 168 ± 7 180 ± 4 179 ± 7
BMI (kg ∙ m-2) 20.3 ± 1.6 b 21.8 ± 1.6 21.6 ± 1.6 22.5 ± 1.7
Body fat (%) 23.3 ± 4.8 a 26.0 ± 4.8 14.1 ± 4.1 a 17.0 ± 5.0
Fat-free mass (kg) 44.4 ± 4.3 45.7 ± 5.2 60.9 ± 6.6 60.8 ± 6.7
RMR
kcal ∙ d-1
kcal ∙ kg-1 ∙ d-1
kcal ∙ kg-1 ∙ h-1
1436 ± 121
25.4 ± 2.5
1.06 ± 0.10
1500 ± 153
24.4 ± 1.4
1.02 ± 0.06
1868 ± 162
26.8 ± 1.6 a
1.12 ± 0.07 a
1835 ± 257
25.3 ± 2.5
1.06 ± 0.10
VO2max
L ∙ min-1
ml ∙ kg-1 ∙ min-1
3.2 ± 0.3 a
56.1 ± 4.5 c
3.0 ± 0.4
48.4 ± 4.4
4.5 ± 0.4 a
64.0 ± 6.2 c
4.1 ± 0.6
56.6 ± 5.0
Maximum metabolic 
equivalent of task
15.2 ± 1.4 c 13.7 ± 1.2 16.3 ± 1.2 a 15.3 ± 1.4
HRmax (bpm) 181 ± 9 a 186 ± 7 189 ± 8 189 ± 7
SHR (bpm) 49 ± 7 a 53 ± 6 48 ± 6 50 ± 7
Recovery HR (bpm) 87 ± 14 90 ± 17 85 ± 11 85 ± 12
PAL 2.1 ± 0.3 b 1.9 ± 0.2 1.9 ± 0.3 1.7 ± 0.2
Table 2: Concurrent validity (tested mode vs. criterion measure) of the two Actiheart modes to estimate VO2max in men and 
women athletes (ATH) and controls (CON).
Women Men
ATH (n=24) CON (n=26) ATH (n=22) CON (n=19)
r value
AHraw
AHcomplete
0.225
0.410 a
0.463 a
0.488 a
-0.069
0.235
0.431
0.480 a
MAE [ml ∙ kg-1 ∙ min-1]
AHraw
AHcomplete
8.8 ± 9.2
3.0 ± 6.5
2.5 ± 7.2
-1.2 ± 8.0
5.2 ± 10.0
-1.5 ± 10.0
1.0 ± 9.1
-5.4 ± 9.8
MAPE [%]
AHraw
AHcomplete
17.7 ± 13.7
10.8 ± 6.5
11.4 ± 10.4
13.6 ± 8.9
13.6 ± 8.6
11.1 ± 10.5
11.4 ± 10.6
14.7 ± 12.2
SEE [ml ∙ kg-1 ∙ min-1]
AHraw
AHcomplete
4.47
4.19
3.98
3.91
6.31
6.15
4.66
4.53
Legend: Results are expressed as mean ± standard deviation. a correlations significant at p < 0.05
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Paterson, 2001; Santo & Golding, 2003; Sykes & Roberts, 2004; 
Webb, Vehrs, George, & Hager, 2014). In our study we found 
a significant relationship between estimated and measured 
VO2max for the total sample, with R
2 0.24 for AHraw and 0.36 for 
AHcomplete. However, when dividing the groups by sex and 
experimental group (ATH and CON), the R2 ranged from 0.01 to 
0.22 for AHraw (with being significant only for women CON), 
and 0.06 to 0.24 for AHcomplete (significant for women ATH 
and CON, and men CON). 
Compared to other studies the absolute measures of agree-
ment showed similar or slightly better validity of the Actiheart 
step test for the estimation of VO2max (SEE: 3.98 – 6.31 ml ∙ kg
-1 ∙ 
min-1 for AHraw and 3.91 – 6.15 ml ∙ kg-1 ∙ min-1 for AHcomplete). 
Previous studies reported a SEE of 6.9 – 8.76 ml ∙ kg-1 ∙ min-
1 for the modified YMCA 3-minute step test in healthy men 
and women (Santo & Golding, 2003) and 3.9 ml ∙ kg-1 ∙ min-1 
for the Chester step test in healthy adults (Sykes & Roberts, 
2004). In well-trained men a SEE of 0.28 L ∙ min-1 was detected 
for the Åstrand-Rhyming step test (Åstrand & Ryhming, 1954). 
Assuming a body mass of 70 kg (not reported in that study) this 
would amount to a SEE of 3.6 ml ∙ kg-1 ∙ min-1.
In the present study, we found a systematic bias of 4.5 ml ∙ kg-1 
∙ min-1 for the total sample for AHraw, indicating that estimated 
VO2max was significantly lower compared to the measured 
VO2max values. When VO2max was estimated by AHcomplete, 
no systematic errors were observed (-1.1 ml ∙ kg-1 ∙ min-1, non-
significant). Knight et al. (2014) observed a systematic bias 
of -6.4 ml ∙ kg-1 ∙ min-1 for the STEP tool protocol in 40 healthy 
men and women, with higher VO2max values in the predictive 
vs. maximal test. For the Chester step test a mean systematic 
bias of 2.8 ml ∙ kg-1 ∙ min-1 was reported in university students, 
Table 3: Parameters of linear regression for maximum oxygen consumption (VO2max; ml ∙ kg
-1 ∙ min-1) in men and women athletes 
(ATH) and controls (CON). Measured VO2max was entered as dependent variable and estimated VO2max by Actiheart was 
the independent variable.
Women Men
ATH (n=24) CON (n=26) ATH (n=22) CON (n=19)
R2
AHraw
AHcomplete
0.051
0.168
0.215
0.238
0.005
0.055
0.186
0.230
p-value
AHraw
AHcomplete
0.291
0.047
0.017
0.011
0.760
0.293
0.065
0.038
Slope
AHraw
AHcomplete
0.11
0.266
0.251
0.234
-0.057
0.153
0.216
0.217
Intercept
AHraw
AHcomplete
50.914
42.004
36.881
36.782
67.394
54.011
44.632
43.183
Legend: Significant p-values are highlighted in bold.
ues was detected (p < 0.05). The relationship between VO2max 
estimated by AHcomplete and the criterion method was sig-
nificant in women ATH and CON and in men CON (p < 0.05).
In Figure 1, the data of AHraw and AHcomplete and the refer-
ence method are presented using Bland-Altman plots. For the 
total sample, the mean bias (± 1.96 SD) was 4.5 (-13.6; 22.6) ml 
∙ kg-1 ∙ min-1 for AHraw, whereas for the AHcomplete no system-
atic errors were observed. Likewise, no systematic errors were 
found in the single groups for both AHraw and AHcomplete, 
except for women ATH when VO2max was estimated by AHraw 
(p < 0.0001; Figure 1). 
Discussion
We evaluated the validity of the Actiheart step test for the esti-
mation of VO2max in men and women along a range of aerobic 
fitness levels, comparing two different data entry modes, AHraw 
(estimated SHR, HRmax and RMR) and AHcomplete (measured 
SHR, HRmax and RMR). Based on MAPE, the Actiheart step test 
is not an acceptable method for estimation of VO2max.
There exist several submaximal step tests for the estimation of 
VO2max. The most common are the Chester step test, the STEP 
tool protocol, the modified YMCA 3-minute step test, and the 
Åstrand-Rhyming step test (Bennett, Parfitt, Davison, & Eston, 
2016). The R2 of previous reported step tests for the estimation 
of VO2max ranged between 0.22 and 0.88 (Francis & Brasher, 
1992; Francis & Culpepper, 1989; Hansen, Jacobs, Thijs, Dendale, 
& Claes, 2016; Knight, Stuckey, & Petrella, 2014; McArdle, Katch, 
Pechar, Jacobson, & Ruck, 1972; Perroni, Cortis, Minganti, 
Cignitti, & Capranica, 2013; Petrella, Koval, Cunningham, & 
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Figure 1: Bland-Altman plots of AHraw and AHcomplete and the reference method (VO2maxmeas) 
for men and women athletes and controls.
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A common issue in studies involving maximal exercise testing 
is the selection bias, often including fitter individuals than the 
general population. In a recent study examining the aerobic 
capacity in the Swiss working population VO2max values of 
33 and 45 ml ∙ kg-1 ∙ min-1 for women and men were reported 
(Mundwiler et al., 2017). In our control group, the mean values 
for VO2max were 48.4 and 56.6 ml ∙ kg
-1 ∙ min-1 for women and 
men, indicating a higher fitness level in the included partici-
pants compared to the general population.
Step tests, in general, are prone to error. For example, perform-
ing a step test requires the person’s ability to maintain a certain 
stepping tempo and technique. Alterations in stepping tech-
nique can affect mechanical efficiency and therefore physi-
ological responses in HR and oxygen consumption (Bennett et 
al., 2016). In addition, performing a step test with a pre-defined 
fixed step height, might introduce potential error since leg 
length, step length, body mass, and morphology vary between 
individuals and these differences might result in different indi-
vidual physiological responses.
The mode AHcomplete requires the measurement of RMR, a 
long-term assessment of SHR, and a maximum exercise test 
for determination of HRmax. These measurements have higher 
financial and time costs, and require the same or even more 
expertise compared to the direct assessment of VO2max. 
However, HRmax can be also measured using a maximum ex-
ercise test without performing a spiroergometry, which makes 
its application possible in settings where the equipment for a 
respiratory gas analysis is not available. Another limitation of 
the AHcomplete mode is that performing a maximum exercise 
test (with or without respiratory gas analysis) is not possible in 
every population, which limits the application of this mode. 
In summary, the mode AHcomplete is only applicable in set-
tings without respiratory gaz analysis equipment and in sub-
jects who can perform a maximum exercise test for determina-
tion of HRmax.  We did not verify the validity of an Actiheart 
mode where RMR and SHR are entered as measured variables, 
and HRmax is estimated. However, using an estimated HRmax 
as endpoint for the estimation of VO2max, such as for AHraw, 
might introduce error since it was shown that estimations of 
HRmax can have a considerable prediction error (Tanaka et al., 
2001). Another potential source of error is the reliance on the 
linear relationship between VO2 and power output, as shown by 
Åstrand and Rodahl (1970). However, Zoladz, Rademaker and 
Sargeant (1995) found a non-linear relationship between VO2 
and power output, which may affect the prediction of VO2max 
by use of submaximal tests. Although the non-linearity might 
occur predominantly at high intensities above the anaerobic 
threshold (Majerczak et al., 2012; Zoladz, Szkutnik, Majerczak, 
& Duda, 1998) this underlines the importance of choosing an 
individual work rate which is not too high. In addition, it was 
shown that there is not always a linear relationship between HR 
and VO2 (Buckley et al., 2004).
indicating that predicted VO2max was significantly lower com-
pared to the measured VO2max during a maximal treadmill test 
(Buckley, Sim, Eston, Hession, & Fox, 2004). We also found a sig-
nificant negative relationship between the mean of measured 
and estimated VO2max and the difference between both meth-
ods, indicating that with increasing VO2max the difference 
between actual and estimated VO2max increased (r = -0.33 for 
AHraw and r = -0.45 for AHcomplete, p < 0.01). This means that 
for participants with very high (such as endurance athletes) or 
very low aerobic capacity (untrained) the difference between 
estimated VO2max by the Actiheart step test and measured 
VO2max is larger. In participants with high aerobic capacity the 
Actiheart step test thus overestimates actual VO2max, whereas 
in participants with low aerobic capacity VO2max is underesti-
mated, independent of which entry mode is used. 
In our study, the absolute difference between measured and 
estimated VO2max was smaller than 5 ml ∙ kg
-1 ∙ min-1 in 41.8% 
of the participants for both AHraw and AHcomplete. However, 
when VO2max was estimated by use of AHraw, only 28.3% (n = 
13) of the athletes had a smaller than 5 ml ∙ kg-1 ∙ min-1 absolute 
difference between measured and estimated VO2max, whereas 
when VO2max was estimated by AHcomplete 45.7% (n = 21) of 
the participants were within 5 ml ∙ kg-1 ∙ min-1. These results indi-
cate that in endurance trained participants the AHcomplete for 
estimating VO2max is more accurate than the AHraw, whereas 
in persons with a good VO2max the AHraw setting is sufficient 
to predict aerobic capacity.
We assume that the underlying equations of the manufacturer 
were originally developed for the estimation of VO2max of the 
general population with a limited range of aerobic capacity 
and not especially for endurance athletes nor for persons with 
low aerobic capacity. Based on our results it would thus seem 
necessary to adapt these equations in order to provide more 
valid VO2max values for a broader range of aerobic capacities.
Strengths and limitations
A strength of the study is the number of included men and 
 women covering the upper range of aerobic capacities. In 
addition, body composition, RMR, and long-term Actiheart 
data (such as SHR and PAL) were available for all participants 
and could be entered into the Actiheart software in order to 
evaluate the effect on the estimation of VO2max. We also put 
effort into measuring “real” VO2max (and not VO2peak) by ap-
plying current criteria for maximal exercise testing (Scharhag-
Rosenberger 2010, Midgley et al. 2008), including the rec-
ommendation that the duration of VO2max tests should last 
between 5 and 26 minutes (Midgley et al., 2008). The specific 
maximal exercise test in our study was performed on a motor-
ized treadmill and the chosen protocol for the determination of 
VO2max was previously shown to induce exhaustion in athletic 
and non-athletic persons after 5 - 9 min (Steiner & Wehrlin, 2011). 
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Conclusion
Based on MAPE, in young adults with good to superior aerobic 
capacity the Actiheart step test was not acceptable for estima-
tion of VO2max. The mode AHraw significantly underestimated 
VO2max in men and women endurance trained athletes, and 
AHcomplete significantly underestimated VO2max in women 
athletes. In endurance trained participants one should manu-
ally enter RMR, HRmax, and SHR into the Actiheart software in 
order to increase the accuracy of the VO2max prediction. Areas 
of future investigation include the repetition of analyses of this 
study when performing the Actiheart step test with other step 
heights, evaluation of the reliability of the step test, inclusion of 
older and more sedentary persons and use in a clinical setting, 
and assessing factors such as HR and VO2 during the Actiheart 
step test to improve the estimation of VO2max.
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